Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 6-7, 2007, Pages 596-603

  Aalto, Hannele ^a   Takala, Annika ^a   Kautiainen, Hannu ^b   Siitonen, Sanna ^c   Repo, Heikki ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD CULTURE; CENTRAL NERVOUS SYSTEM INFECTION; CHOLECYSTITIS; COMMUNICABLE DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION FUNCTION; DEATH; DIARRHEA; DISEASE SEVERITY; ENDOCARDITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; LIVER ABSCESS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; PREDICTION; PROTEIN BLOOD LEVEL; SEPSIS; SINUSITIS; SKIN INFECTION; SPONDYLITIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PROGNOSIS;

EID: 34347359643     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701199808     Document Type: Article

References (26)

1. Pugin, J., Heumann, ID, Tomasz, A., Kravchenko, VV, Akamatsu, Y. and Nishijima, M. (1994) CD14 is a pattern recognition receptor. Immunity, 1, pp. 509-516.
2. Yoshimura, A., Lien, E., Ingalls, RR, Tuomanen, E., Dziarski, R. and Golenbock, D. (1999) Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol, 163, pp. 1-5.
3. Bazil, V. and Strominger, JL. (1991) Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol, 147, pp. 1567-1574.
4. Lin, RY, Astiz, ME, Saxon, JC and Rackow, EC. (1993) Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest, 104, pp. 847-853.
5. Bone, RC, Sibbald, WJ and Sprung, CL. (1992) The ACCP-SCCM consensus conference on sepsis and organ failure. Chest, 101, pp. 1481-1483.
6. Heinzelmann, M., Mercer-Jones, M., Cheadle, WG and Polk Jr, HC (1996) CD14 expression in injured patients correlates with outcome. Ann Surg, 224, pp. 91-96.
7. Blondin, C., Dur, A Le, Cholley, B., Caroff, M. and Haeffner-Cavaillon, N. (1997) Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes. Eur J Immunol, 27, pp. 3303-3309.
8. Pugin, J., Schurer-Maly, CC, Leturcq, D., Moriarty, A., Ulevitch, RJ and Tobias, PS. (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A, 90, pp. 2744-2748.
9. Wenisch, C., Wenisch, H., Parschalk, B., Vanijanonta, S., Burgmann, H. and Exner, M. (1996) Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria. Clin Exp Immunol, 105, pp. 74-78.
10. Landmann, R., Reber, AM, Sansano, S. and Zimmerli, W. (1996) Function of soluble CD14 in serum from patients with septic shock. J Infect Dis, 173, pp. 661-668.
11. Landmann, R., Zimmerli, W., Sansano, S., Link, S., Hahn, A. and Glauser, MP (1995) Increased circulating soluble CD14 is associated with high mortality in Gram-negative septic shock. J Infect Dis, 171, pp. 639-644.
12. Burgmann, H., Winkler, S., Locker, GJ, Presterl, E., Laczika, K. and Staudinger, T. (1996) Increased serum concentration of soluble CD14 is a prognostic marker in Gram-positive sepsis. Clin Immunol Immunopathol, 80, pp. 307-310.
13. Aalto, H., Takala, A., Kautiainen, H. and Repo, H. (2005) Peripheral blood phagocyte CD14 and CD11b expression on admission to hospital in relation to mortality among patients with community acquired infection. Inflamm Res, 54, pp. 428-434.
14. Gluck, T., Silver, J., Epstein, M., Cao, P., Farber, B. and Goyert, SM. (2001) Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis. Eur J Med Res, 6, pp. 351-358.
15. Serke, S., van Lessen, A. and Huhn, D. (1998) Quantitative fluorescence flow cytometry: A comparison of the 3 techniques for direct and indirect immunofluorescence. Cytometry, 33, pp. 179-187.
16. Repo, H., Jansson, SE and Leirisalo-Repo, M. (1993) Flow cytometric determination of CD11b up-regulation in vivo. J Immunol Methods, 164, pp. 193-202.
17. Marchant, A., Duchow, J., Delville, JP and Goldman, M. (1992) Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in human whole blood. Eur J Immunol, 22, pp. 1663-1665.
18. Sucic, M., Kolevska, T., Kopjar, B., Kosanovic, M., Drobnjak, M. and Zalud, I. (1989) Accuracy of routine flow-cytometric bitmap selection for 3 leukocyte populations. Cytometry, 10, pp. 442-447.
19. Su, GL, Dorko, K., Strom, SC, Nussler, AK and Wang, SC. (1999) CD14 expression and production by human hepatocytes. J Hepatol, 31, pp. 435-442.
20. Bas, S., Gauthier, BR, Spenato, U., Stingelin, S. and Gabay, C. (2004) CD14 is an acute-phase protein. J Immunol, 172, pp. 4470-4479.
21. Dziarski, R., Viriyakosol, S., Kirkland, TN and Gupta, D. (2000) Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide. Infect Immun, 68, pp. 5254-5260.
22. Hailman, E. and Wright, SD. (1997) Lipopolysaccharide binding protein and soluble CD14 catalyse exchange of phospholipids. J Clin Invest, 99, pp. 315-324.
23. Docke, WD, Randow, F., Syrbe, U., Krausch, D., Asadullah, K. and Reinke, P. (1997) Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment. Nat Med, 3, pp. 678-681.
24. Wolk, K., Docke, WD, Von Baehr, V., Volk, HD and Sabat, R. (2000) Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood, 96, pp. 218-223.
25. Piani, A., Hossle, JP, Birchler, T., Siegrist, CA, Heumann, D. and Davies, G. (2000) Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness. Eur J Immunol, 30, pp. 3140-3146.
26. Rosenbloom, AJ, Linden, PK, Dorrance, A., Penkosky, N., Cohen-Melamed, MH and Pinsky, MR. (2005) Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in non-neutropenic patients. Chest, 127, pp. 2139-2150.